395 related articles for article (PubMed ID: 33164570)
21. Efficacy of Ertugliflozin on Heart Failure-Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease: Results of the VERTIS CV Trial.
Cosentino F; Cannon CP; Cherney DZI; Masiukiewicz U; Pratley R; Dagogo-Jack S; Frederich R; Charbonnel B; Mancuso J; Shih WJ; Terra SG; Cater NB; Gantz I; McGuire DK;
Circulation; 2020 Dec; 142(23):2205-2215. PubMed ID: 33026243
[TBL] [Abstract][Full Text] [Related]
22. Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition).
Pandey A; Khan H; Newman AB; Lakatta EG; Forman DE; Butler J; Berry JD
Hypertension; 2017 Feb; 69(2):267-274. PubMed ID: 27993954
[TBL] [Abstract][Full Text] [Related]
23. Validation of the WATCH-DM and TRS-HF
Segar MW; Patel KV; Hellkamp AS; Vaduganathan M; Lokhnygina Y; Green JB; Wan SH; Kolkailah AA; Holman RR; Peterson ED; Kannan V; Willett DL; McGuire DK; Pandey A
J Am Heart Assoc; 2022 Jun; 11(11):e024094. PubMed ID: 35656988
[TBL] [Abstract][Full Text] [Related]
24. Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study.
de Simone G; Devereux RB; Roman MJ; Chinali M; Barac A; Panza JA; Lee ET; Galloway JM; Howard BV
Nutr Metab Cardiovasc Dis; 2013 Apr; 23(4):285-91. PubMed ID: 21940153
[TBL] [Abstract][Full Text] [Related]
25. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial.
; Gregg EW; Jakicic JM; Blackburn G; Bloomquist P; Bray GA; Clark JM; Coday M; Curtis JM; Egan C; Evans M; Foreyt J; Foster G; Hazuda HP; Hill JO; Horton ES; Hubbard VS; Jeffery RW; Johnson KC; Kitabchi AE; Knowler WC; Kriska A; Lang W; Lewis CE; Montez MG; Nathan DM; Neiberg RH; Patricio J; Peters A; Pi-Sunyer X; Pownall H; Redmon B; Regensteiner J; Rejeski J; Ribisl PM; Safford M; Stewart K; Trence D; Wadden TA; Wing RR; Yanovski SZ
Lancet Diabetes Endocrinol; 2016 Nov; 4(11):913-921. PubMed ID: 27595918
[TBL] [Abstract][Full Text] [Related]
26. Left Atrial Strain to Predict Stroke in Patients With Acute Heart Failure and Sinus Rhythm.
Park JH; Hwang IC; Park JJ; Park JB; Cho GY
J Am Heart Assoc; 2021 Jul; 10(13):e020414. PubMed ID: 34187174
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular Health Status and Incidence of Heart Failure in the Framingham Offspring Study.
Nayor M; Enserro DM; Vasan RS; Xanthakis V
Circ Heart Fail; 2016 Jan; 9(1):e002416. PubMed ID: 26699391
[TBL] [Abstract][Full Text] [Related]
28. Changes in body mass index and waist circumference and heart failure in type 2 diabetes mellitus.
Zhou Y; Chai X; Yang G; Sun X; Xing Z
Front Endocrinol (Lausanne); 2023; 14():1305839. PubMed ID: 38179309
[TBL] [Abstract][Full Text] [Related]
29. Impact of Diabetes Mellitus on Ventricular Structure, Arterial Stiffness, and Pulsatile Hemodynamics in Heart Failure With Preserved Ejection Fraction.
Chirinos JA; Bhattacharya P; Kumar A; Proto E; Konda P; Segers P; Akers SR; Townsend RR; Zamani P
J Am Heart Assoc; 2019 Feb; 8(4):e011457. PubMed ID: 30764699
[TBL] [Abstract][Full Text] [Related]
30. Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction.
Myhre PL; O'Meara E; Claggett BL; de Denus S; Jarolim P; Anand IS; Beldhuis IE; Fleg JL; Lewis E; Pitt B; Rouleau JL; Solomon SD; Pfeffer MA; Desai AS
Circ Heart Fail; 2018 Nov; 11(11):e005312. PubMed ID: 30571192
[TBL] [Abstract][Full Text] [Related]
31. Changes in regional body composition over 8 years in a randomized lifestyle trial: The look AHEAD study.
Pownall HJ; Schwartz AV; Bray GA; Berkowitz RI; Lewis CE; Boyko EJ; Jakicic JM; Chen H; Heshka S; Gregg EW; Johnson KC;
Obesity (Silver Spring); 2016 Sep; 24(9):1899-905. PubMed ID: 27465756
[TBL] [Abstract][Full Text] [Related]
32. Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study.
Gerber Y; Weston SA; Berardi C; McNallan SM; Jiang R; Redfield MM; Roger VL
Am J Epidemiol; 2013 Oct; 178(8):1272-80. PubMed ID: 23997209
[TBL] [Abstract][Full Text] [Related]
33. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study.
Lewis EF; Moye LA; Rouleau JL; Sacks FM; Arnold JM; Warnica JW; Flaker GC; Braunwald E; Pfeffer MA;
J Am Coll Cardiol; 2003 Oct; 42(8):1446-53. PubMed ID: 14563590
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast Growth Factor-23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA.
Almahmoud MF; Soliman EZ; Bertoni AG; Kestenbaum B; Katz R; Lima JAC; Ouyang P; Miller PE; Michos ED; Herrington DM
J Am Heart Assoc; 2018 Sep; 7(18):e008334. PubMed ID: 30371180
[TBL] [Abstract][Full Text] [Related]
35. Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective.
Gerber Y; Weston SA; Enriquez-Sarano M; Berardi C; Chamberlain AM; Manemann SM; Jiang R; Dunlay SM; Roger VL
Circ Heart Fail; 2016 Jan; 9(1):e002460. PubMed ID: 26699392
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
[TBL] [Abstract][Full Text] [Related]
37. Incidence, Determinants and Mortality of Heart Failure Associated With Medical-Surgical Procedures in Patients ≥ 65 Years of Age (from the Cardiovascular Health Study).
Shah M; Rodriguez CJ; Bartz TM; Lyles MF; Kizer JR; Aurigemma GP; Gardin JM; Gottdiener JS
Am J Cardiol; 2021 Aug; 153():71-78. PubMed ID: 34175107
[TBL] [Abstract][Full Text] [Related]
38. A comparison of non-invasive methods of measuring body composition in patients with heart failure: a report from SICA-HF.
Shah P; Abel AAI; Boyalla V; Pellicori P; Kallvikbacka-Bennett A; Sze S; Cleland JGF; Clark AL
ESC Heart Fail; 2021 Oct; 8(5):3929-3934. PubMed ID: 34216106
[TBL] [Abstract][Full Text] [Related]
39. Body Weight Variability and Risk of Cardiovascular Outcomes and Death in the Context of Weight Loss Intervention Among Patients With Type 2 Diabetes.
Kaze AD; Santhanam P; Erqou S; Ahima RS; Bertoni AG; Echouffo-Tcheugui JB
JAMA Netw Open; 2022 Feb; 5(2):e220055. PubMed ID: 35179583
[TBL] [Abstract][Full Text] [Related]
40. Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
Kristensen SL; Mogensen UM; Jhund PS; Petrie MC; Preiss D; Win S; Køber L; McKelvie RS; Zile MR; Anand IS; Komajda M; Gottdiener JS; Carson PE; McMurray JJ
Circulation; 2017 Feb; 135(8):724-735. PubMed ID: 28052977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
